Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis

NCT01728727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis
End Stage Liver Disease

Interventions

OTHER: UC-MSC transplantation
OTHER: conventional treatment

Sponsor

Air Force Military Medical University, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]